Core Viewpoint - The stock price of Touyun Biotechnology (01332) experienced a significant increase of nearly 900% over the previous three trading days, followed by a sharp decline of over 28% today, currently trading at HKD 0.39 with a transaction volume of HKD 8.95 million [1] Group 1: Stock Performance - The maximum cumulative increase in stock price over the last three trading days was close to 900% [1] - Today's stock price has dropped by 22% as of the report, indicating a significant reversal in market sentiment [1] Group 2: Strategic Developments - Touyun Biotechnology announced an unusual fluctuation in stock price and trading volume [1] - A strategic cooperation agreement was signed on October 23 between its wholly-owned subsidiary, Shanxi Touyun, and several companies, including Shenzhen Building Supply Chain Technology, Henan Guozi Marketing Management, and Beijing Huanjia Biological Technology [1] - The agreement stipulates that from 2026 to 2028, the sales consortium will purchase no less than RMB 1 billion worth of Rhizoclonium and related products from Shanxi Touyun [1]
透云生物回落逾28% 公司回应股价异动 附属签10亿元莱茵衣藻采购框架协议